Swiss National Bank
XERS icon

Swiss National Bank’s Xeris Biopharma Holdings XERS Stock Holding History

Swiss National Bank’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.67M Buy
337,500
+9,200
+3% +$58.7K ﹤0.01% 1777
2026
Q1 		$1.9M Buy
328,300
+9,900
+3% +$65.6K ﹤0.01% 1871
2025
Q4 		$2.5M Buy
318,400
+8,000
+3% +$63K ﹤0.01% 1760
2025
Q3 		$2.53M Buy
+310,400
New +$2.06M ﹤0.01% 1736

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return

Swiss National Bank's XERS Position: Q2 2026 in Review

Swiss National Bank increased its Xeris Biopharma Holdings (XERS) stake by 2.8% in Q2 2026, buying an estimated $58.7K and bringing the position to 337,500 shares worth $2.67M. The position accounts for ﹤0.01% of the portfolio, ranked #1777.

Swiss National Bank first reported a position in XERS in Q3 2025 and has held it in 4 quarters since. 91 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Swiss National Bank held 337,500 shares of Xeris Biopharma Holdings worth $2.67M as of Q2 2026.
  • Swiss National Bank bought 9,200 Xeris Biopharma Holdings shares in Q2 2026, an estimated $58.7K.
  • Xeris Biopharma Holdings made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1777 holding.
  • Swiss National Bank first reported a position in Xeris Biopharma Holdings in Q3 2025 and has held it in 4 quarters since.
  • 91 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.